长风药业(02652)

19.860-0.400-1.97%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
长风药业
所属市场
SEHK
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.cfpharmtech.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
长风药业股份有限公司是一家专注于吸入技术及吸入药物的研发、生产及商业化的中国公司。该公司的产品组合主要针对呼吸系统疾病，包括哮喘、慢性阻塞性肺病（COPD）和过敏性鼻炎。该公司主要产品包括CF017，即治疗支气管哮喘的吸入用布地奈德混悬液，以及CF018，一种用于治疗过敏性鼻炎的氮䓬斯汀氟替卡松鼻喷雾剂。该公司主要在中国国内市场开展业务。
- 06-02
  股份购回
  (1) 2025年经审核综合财务报表；(2) 2025年年报；(3) 选举第四届董事会；(4)选举第四届监事会；(5) 续聘2026年核数师；(6) 建议修订H股奖励计划；(7) 发行H股的一般授权；(8) 回购H股的股份回购授权；及(9) 股东周年大会通告
  (1) 2025年经审核综合财务报表；(2) 2025年年报；(3) 选举第四届董事会；(4)选举第四届监事会；(5) 续聘2026年核数师；(6) 建议修订H股奖励计划；(7) 发行H股的一般授权；(8) 回购H股的股份回购授权；及(9) 股东周年大会通告
- 04-30
  年度报告
  二零二五年年报
  二零二五年年报
- 03-30
  年度报告
  截至2025年12月31日止年度的年度业绩公告
  截至2025年12月31日止年度的年度业绩公告
- 03-20
  业绩预告
  内幕消息盈利预警
  内幕消息盈利预警
- 2025-11-26
  股份购回
  建议股份购回授权建议采纳H股奖励计划建议授权董事会及╱或授权人士办理H股奖励计划相关事宜及2025年第一次股东特别大会通告
  建议股份购回授权建议采纳H股奖励计划建议授权董事会及╱或授权人士办理H股奖励计划相关事宜及2025年第一次股东特别大会通告
- 2025-09-26
  股份发售
  全球发售
  全球发售

分时
5日
日
周
月

数据加载中...

最高

20.400

今开

20.400

量比

1.51

最低

19.580

昨收

20.260

换手率

0.12%

热议股票

{"pagemeta":{"title":"长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供长风药业(02652)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"长风药业,02652,长风药业股票,长风药业股票老虎,长风药业股票老虎国际,长风药业行情,长风药业股票行情,长风药业股价,长风药业股市,长风药业股票价格,长风药业股票交易,长风药业股票购买,长风药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"长风药业(02652)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供长风药业(02652)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"02652","data":{"stockData":{"symbol":"02652","market":"HK","secType":"STK","nameCN":"长风药业","latestPrice":19.86,"timestamp":1780895660660,"preClose":20.26,"halted":0,"volume":352500,"delay":0,"changeRate":-0.01974333662388954,"floatShares":302000000,"shares":411000000,"eps":0.007620715052457552,"marketStatus":"交易中","change":-0.4,"latestTime":"06-08 13:14:31","open":20.4,"high":20.4,"low":19.58,"amount":7006630,"amplitude":0.040474,"askPrice":19.86,"askSize":1000,"bidPrice":19.68,"bidSize":500,"shortable":3,"etf":0,"ttmEps":0.007620715052457552,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1780906200000},"marketStatusCode":2,"adr":0,"listingDate":1759852800000,"exchange":"SEHK","adjPreClose":20.26,"openAndCloseTimeList":[[1780882200000,1780891200000],[1780894800000,1780905600000]],"volumeRatio":1.508602,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"tweetData":null,"newsData":null,"noticeData":{"listData":[{"cdn_pdf":true,"hasAttachments":false,"id":"21343907","market":"hk","labels":[],"media":"港交所","original_id":"N.HKDKkMSqPQ61","pdf_url":"https://static.tigerbbs.com/a4a1247080e74cad9646abb61b73fffe","pub_time":1780411800000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"(1) 2025年经审核综合财务报表；(2) 2025年年报；(3) 选举第四届董事会；(4)选举第四届监事会；(5) 续聘2026年核数师；(6) 建议修订H股奖励计划；(7) 发行H股的一般授权；(8) 回购H股的股份回购授权；及(9) 股东周年大会通告","symbol":"02652","title":"(1) 2025年经审核综合财务报表；(2) 2025年年报；(3) 选举第四届董事会；(4)选举第四届监事会；(5) 续聘2026年核数师；(6) 建议修订H股奖励计划；(7) 发行H股的一般授权；(8) 回购H股的股份回购授权；及(9) 股东周年大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0602/2026060202929_c.pdf","us_notice_code":"通函 - [一般性授权 / 回购股份的说明函件 / 在股东批准的情况下重选或委任董事 / 股份计划]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2026-06-02 22:50","pubTimestamp":1780411800,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"21196459","market":"hk","labels":[],"media":"港交所","original_id":"N.HKDwfhivPnDh","pdf_url":"https://static.tigerbbs.com/68108c822be44f84b013e2433e719c8e","pub_time":1777552080000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"二零二五年年报","symbol":"02652","title":"二零二五年年报","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0430/2026043003481_c.pdf","us_notice_code":"财务报表/环境、社会及管治资料 - [年报]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2026-04-30 20:28","pubTimestamp":1777552080,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20913730","market":"hk","labels":[],"media":"港交所","original_id":"N.HKC2LNW5zyf1","pdf_url":"https://static.tigerbbs.com/f44a424cab5e4192bb8da829a93313f2","pub_time":1774859400000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"截至2025年12月31日止年度的年度业绩公告","symbol":"02652","title":"截至2025年12月31日止年度的年度业绩公告","titleType":"年度报告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0330/2026033000447_c.pdf","us_notice_code":"公告及通告 - [末期业绩]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","event_type":"important_notice","event_name":"年度报告","pubTime":"2026-03-30 16:30","pubTimestamp":1774859400,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20866941","market":"hk","labels":[],"media":"港交所","original_id":"N.HKcEEVHrKtBA","pdf_url":"https://static.tigerbbs.com/0c578a5342344ed9ac9af256c42dc000","pub_time":1774017000000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"内幕消息盈利预警","symbol":"02652","title":"内幕消息盈利预警","titleType":"业绩预告","type":"hkFinancials","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2026/0320/2026032001829_c.pdf","us_notice_code":"公告及通告 - [盈利警告 / 内幕消息]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Earnings Estimation","event_type":"important_notice","event_name":"业绩预告","pubTime":"2026-03-20 22:30","pubTimestamp":1774017000,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20453040","market":"hk","labels":[],"media":"港交所","original_id":"N.HKCGaoFZrfGD","pdf_url":"https://static.tigerbbs.com/fca5bc3f08c94671b8fc58e1154fd57f","pub_time":1764151800000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"建议股份购回授权建议采纳H股奖励计划建议授权董事会及╱或授权人士办理H股奖励计划相关事宜及2025年第一次股东特别大会通告","symbol":"02652","title":"建议股份购回授权建议采纳H股奖励计划建议授权董事会及╱或授权人士办理H股奖励计划相关事宜及2025年第一次股东特别大会通告","titleType":"股份购回","type":"hkShares","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/1126/2025112600884_c.pdf","us_notice_code":"通函 - [一般性授权 / 回购股份的说明函件 / 股份计划]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"股权股本","type_name_en":"Equity Change","titleTypeEn":"Share Repurchase","event_type":"important_notice","event_name":"股份购回","pubTime":"2025-11-26 18:10","pubTimestamp":1764151800,"notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":true,"hasAttachments":false,"id":"20207648","market":"hk","labels":[],"media":"港交所","original_id":"N.HK93R6k1prP4","pdf_url":"https://static.tigerbbs.com/38dbffd0126647e3a27f09335ddbcad1","pub_time":1758839100000,"showTitleType":false,"size":0,"source":"hk_ex_notice","summary":"全球发售","symbol":"02652","title":"全球发售","titleType":"股份发售","type":"hkIPO","url":"https://www.hkexnews.hk/listedco/listconews/sehk/2025/0926/2025092600042_c.pdf","us_notice_code":"上市文件 - [发售以供认购]","us_title_en":"","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","type_name":"上市文件","type_name_en":"Listing Document","titleTypeEn":"Shares Subscription","event_type":"important_notice","event_name":"股份发售","pubTime":"2025-09-26 06:25","pubTimestamp":1758839100,"notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":true},"companyData":{"profile":{"websiteUrl":"http://www.cfpharmtech.com","stockEarnings":[{"period":"1week","weight":-0.0882},{"period":"1month","weight":-0.0664},{"period":"3month","weight":-0.4052},{"period":"6month","weight":-0.4635},{"period":"1year","weight":0.3736},{"period":"ytd","weight":-0.4211}],"compareEarnings":[{"period":"1week","weight":-0.0088},{"period":"1month","weight":-0.0478},{"period":"3month","weight":-0.0309},{"period":"6month","weight":-0.0431},{"period":"1year","weight":0.0441},{"period":"ytd","weight":-0.0261}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"长风药业股份有限公司是一家专注于吸入技术及吸入药物的研发、生产及商业化的中国公司。该公司的产品组合主要针对呼吸系统疾病，包括哮喘、慢性阻塞性肺病（COPD）和过敏性鼻炎。该公司主要产品包括CF017，即治疗支气管哮喘的吸入用布地奈德混悬液，以及CF018，一种用于治疗过敏性鼻炎的氮䓬斯汀氟替卡松鼻喷雾剂。该公司主要在中国国内市场开展业务。","exchange":"SEHK","name":"长风药业","nameEN":"CF PHARMTECH"},"aProfile":null}}}